• ACRIVASTINE CHEMBL1224 FDA Approved

    Alternate Names:

    Acrivastine
    Semprex
    Benadryl Allgy Relief Plus Decongest
    BW-825C
    MOLPORT-005-942-272
    E)- (9CI)
    ACRIVASTINUM [LATIN]
    (E)-6-((E)-3-(1-PYRROLIDINYL)-1-P-TOLYLPROPENYL)-2-PYRIDINEACRYLIC ACID
    ACRIVASTINA [SPANISH]
    DAP001343
    (E)-3-[6-[(E)-1-(4-METHYLPHENYL)-3-PYRROLIDIN-1-YLPROP-1-ENYL]PYRIDIN-2-YL]PROP-2-ENOIC ACID
    BIDD:GT0209
    BW 825C
    2-PROPENOIC ACID, 3-(6-(1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL)-2-PYRIDINYL)-, (E,E)-
    87848-99-5
    I14-8671
    BW A825C
    AC-912
    ACRIVASTINA
    ACRIVASTINUM
    (2E)-3-{6-[(1E)-1-(4-METHYLPHENYL)-3-PYRROLIDIN-1-YLPROP-1-EN-1-YL]PYRIDIN-2-YL}PROP-2-ENOIC ACID
    AC1Q5T9P
    BW 0270C
    LS-178016
    AC1NR4LM
    ( E,E )-3-[6-[1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL]-2-PYRIDINYL]-2-PROPENOIC ACID
    (E)-6-((E)-3-(1-PYRROLIDINYL-1-P-TOLYLPROPENYL)-2-PYRIDINACRYLSAEURE
    D02760
    ACRIVASTINE (USAN/INN)
    ACRIVASTIN
    3-{6-[1-(4-METHYLPHENYL)-3-(PYRROLIDIN-1-YL)PROP-1-EN-1-YL]PYRIDIN-2-YL}PROP-2-ENOIC ACID
    AKOS005067182
    5284514
    2-PROPENOIC ACID, 3-[6-[(1E)-1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPEN-1-YL]-2-PYRIDINYL]-, (2E)-
    ACRIVASTINE [USAN:INN:BAN]
    2-PROPENOIC ACID, 3-[6-[1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL]-2-PYRIDINYL]-, (E,E)-
    CID5284514
    UNII-A20F9XAI7W
    C22H24N2O2
    17396918
    -PROPENOIC ACID, 3-[6-[(1E)-1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL]-2-PYRIDINYL]-, (2
    (2E)-3-{6-[(1E)-1-(4-METHYLPHENYL)-3-(PYRROLIDIN-1-YL)PROP-1-EN-1-YL]PYRIDIN-2-YL}ACRYLIC ACID
    (2E)-3-[6-[(1E)-1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPEN-1-YL]-2-PYRIDINYL]-2-PROPENOIC ACID
    (E)-3-[6-[(E)-1-(P-TOLYL)-3-PYRROLIDIN-1-YL-PROP-1-ENYL]-2-PYRIDYL]PROP-2-ENOIC ACID
    Q-200590
    54338-EP2308562A2
    CAS-87848-99-5
    SMR004701250
    L917
    HE400988
    DR001753
    BC224208
    AN-15417
    KM2560
    TOX21_113015
    ZINC3776633
    MLS006010115
    DSSTOX_GSID_22555
    DSSTOX_RID_76625
    A20F9XAI7W
    SCHEMBL4702
    DSSTOX_CID_2555
    BW825C
    NCGC00182053-02
    CHEBI:83168
    Semprex D
    DB09488

    Drug Info:

    Drug Categories respiratory system
    Drug Categories pyridines
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories neurotransmitter agents
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories histamine h1 antagonists, non-sedating
    Drug Categories histamine h1 antagonists
    Drug Categories histamine antagonists
    Drug Categories histamine agents
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories chemical actions and uses
    Drug Categories antihistamines for systemic use
    Drug Groups approved
    Drug Type small molecule
    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Histamine H1 receptor antagonist
    Direct Interaction yes

    Publications:

    • Version: 5.0.8

    Alternate Names:
    ACRIVASTINE DrugBank Drug Name
    (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid Drug Synonym
    87848-99-5 CAS Number

    Drug Info:
    Drug Type small molecule
    Drug Groups approved
    Drug Categories antihistamines for systemic use

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    -PROPENOIC ACID, 3-[6-[(1E)-1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL]-2-PYRIDINYL]-, (2 Drug Synonym
    17396918 Pubchem SId
    C22H24N2O2 Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    ACRIVASTINE pubchem_primary_name
    5284514 PubChem CID
    SEMPREX Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: